US EditionPublished • loading... • Updated
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing A 9.88% Potential Upside For Investors
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing A 9.88% Potential Upside For Investors
Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specializes in medical devices with a focus on life science research and clinical diagnostics. Founded in 1952 and headquartered in Hercules, California, Bio-Rad has established a significant presence across the United States, Europe, Asia, Canada, and Latin America. With a market capitalization of $8.54 billion, it continues to be a noteworthy contender in the …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
